These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 26021633)

  • 21. Scot Matkovich: Keep on Keeping on.
    Williams R
    Circ Res; 2018 Jan; 122(2):202-204. PubMed ID: 29348247
    [No Abstract]   [Full Text] [Related]  

  • 22. Basic Cardiovascular Sciences Scientific Sessions 2018.
    McNamara JW; Grimes KM; Sadayappan S
    Circ Res; 2018 Oct; 123(9):1024-1029. PubMed ID: 30355166
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A virtual issue for the CBCS Summer School 2017: focus on hot topics.
    Sipido KR; Vandevelde W
    Cardiovasc Res; 2017 Jun; 113(7):708-710. PubMed ID: 28525919
    [No Abstract]   [Full Text] [Related]  

  • 24. Progress in pharmacogenomics: bridging the gap from research to practice.
    Cascorbi I; Tyndale R
    Clin Pharmacol Ther; 2014 Mar; 95(3):231-5. PubMed ID: 24548984
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cardiovascular pharmacogenomics.
    Roden DM; Johnson JA; Kimmel SE; Krauss RM; Medina MW; Shuldiner A; Wilke RA
    Circ Res; 2011 Sep; 109(7):807-20. PubMed ID: 21921273
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Network medicine: a new paradigm for cardiovascular disease research and beyond.
    Menche J
    Cardiovasc Res; 2017 Aug; 113(10):e29-e30. PubMed ID: 28899006
    [No Abstract]   [Full Text] [Related]  

  • 27. [Cardiovascular diseases: present and future based on molecular biology].
    Oseguera Moguel J
    Rev Invest Clin; 2003; 55(2):155-60. PubMed ID: 12827919
    [No Abstract]   [Full Text] [Related]  

  • 28. Clinical utility of pharmacogenetic biomarkers in cardiovascular therapeutics: a challenge for clinical implementation.
    Ong FS; Deignan JL; Kuo JZ; Bernstein KE; Rotter JI; Grody WW; Das K
    Pharmacogenomics; 2012 Mar; 13(4):465-75. PubMed ID: 22380001
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacogenomics and cardiovascular disease.
    Weeke P; Roden DM
    Curr Cardiol Rep; 2013 Jul; 15(7):376. PubMed ID: 23689943
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cardiovascular Pharmacokinetics, Pharmacodynamics, and Pharmacogenomics for the Clinical Practitioner.
    Sleder AT; Kalus J; Lanfear DE
    J Cardiovasc Pharmacol Ther; 2016 Jan; 21(1):20-6. PubMed ID: 26054891
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cardiovascular pharmacogenetics.
    Myburgh R; Hochfeld WE; Dodgen TM; Ker J; Pepper MS
    Pharmacol Ther; 2012 Mar; 133(3):280-90. PubMed ID: 22123178
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Time to Check the Clock in Cardiovascular Research and Medicine.
    Montaigne D; Staels B
    Circ Res; 2018 Aug; 123(6):648-650. PubMed ID: 30355237
    [No Abstract]   [Full Text] [Related]  

  • 33. Pharmacogenomics of cardiovascular drugs and adverse effects in pediatrics.
    Visscher H; Amstutz U; Sistonen J; Ross CJ; Hayden MR; Carleton BC
    J Cardiovasc Pharmacol; 2011 Sep; 58(3):228-39. PubMed ID: 21386709
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Pharmacogenomics and pharmacoproteomics: a strategy for cardio-vascular drugs].
    Siest G; Marteau JB; Maumus S; Berrahmoune H; Jeannesson E; Samara A; Batt AM; Visvikis-Siest S
    Ann Pharm Fr; 2007 May; 65(3):203-10. PubMed ID: 17489077
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A critical assessment of the role of pharmacogenomics and pharmacogenetics approaches to cardiovascular diseases.
    Amouyel P
    Pharmacogenomics J; 2001; 1(2):95-7. PubMed ID: 11911447
    [No Abstract]   [Full Text] [Related]  

  • 36. Cardiovascular pharmacogenomics.
    Johnson JA; Cavallari LH
    Exp Physiol; 2005 May; 90(3):283-9. PubMed ID: 15778411
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacogenomics and management of cardiovascular disease.
    Howe LA
    Nurse Pract; 2009 Aug; 34(8):28-35; quiz 36. PubMed ID: 19638892
    [No Abstract]   [Full Text] [Related]  

  • 38. Pharmacogenomics of cardiovascular pharmacology: pharmacogenomic network of cardiovascular disease models.
    Tanaka T; Oka T; Shimada Y; Umemoto N; Kuroyanagi J; Sakamoto C; Zang L; Wang Z; Nishimura Y
    J Pharmacol Sci; 2008 May; 107(1):8-14. PubMed ID: 18490853
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacogenetics of chronic cardiovascular drugs: applications and implications.
    Zineh I; Johnson JA
    Expert Opin Pharmacother; 2006 Aug; 7(11):1417-27. PubMed ID: 16859425
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacogenomics and cardiovascular drugs: need for integrated biological system with phenotypes and proteomic markers.
    Siest G; Marteau JB; Maumus S; Berrahmoune H; Jeannesson E; Samara A; Batt AM; Visvikis-Siest S
    Eur J Pharmacol; 2005 Dec; 527(1-3):1-22. PubMed ID: 16316654
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.